Q3 2022 Putnam Growth Opportunities Fund Q&A
- In periods when growth becomes scarce, we want to own businesses that are unique, with strong balance sheets and revenue visibility.
- We often favor the "enablers" of growth themes and trends. These are also known as pick-and-shovel businesses.
- To help manage risk, we analyze each company's vulnerabilities and, when possible, assess how it has performed through difficult times in the past.
What can you tell us about your approach in this year's difficult market environment?
There is no question that large-cap growth stocks have struggled throughout 2022. But we believe great companies can become even better in challenging markets. In periods when growth becomes scarce, we want to own businesses that are unique, with strong balance sheets and revenue visibility. We look for companies that are competitively advantaged, are market share gainers, and have customers that depend heavily on them. We want businesses with the ability to grow at above-market rates and to sustain that growth across an economic cycle. We believe these are the companies that will distinguish themselves from the competition and the stocks that are most likely to return to favor.
As part of your theme-based approach, you look for "enablers." What does that mean?
In our view, it's not enough to simply identify a business that is associated with a long-term growth theme. We scrutinize businesses in the context of their industries overall, and often we favor the "enablers" of growth themes and trends. Also known as pick-and-shovel businesses, these companies provide products or services that enable the growth of the overall industry.
An example of an enabler can be found within our personalized medicine theme. Personalized medicine refers to the customization of medical treatments based on an individual's specific needs and genetic makeup. Many companies are making great strides in cell and gene therapy, with thousands of treatments in various phases of development.
However, when it comes to biopharmaceuticals, there are many complexities, uncertainties, and possible outcomes. Rather than trying to forecast which individual drugs and treatments will be successful, we are invested in Lonza, a company that opened the world's largest dedicated cell-and-gene-therapy facility for businesses that are developing drugs. Lonza is the outsourced manufacturer for over 1,000 different therapies across modalities. We believe Lonza should benefit as any of these treatments successfully come to market.
In light of the market challenges, what can you tell us about your risk management?
Our investment process includes an element of research that many investors don't consider: looking beyond growth potential to analyze the vulnerabilities of a business. Before any company enters our portfolio, we need to know what could go wrong. We analyze each company's potential weaknesses and, when possible, assess how it has performed through difficult times in the past. We also discuss this with management teams of the companies themselves. We analyze the range of operational and financial outcomes for a business. To help control risk at the portfolio level, we target companies with a narrow range of outcomes and we prefer capital-light businesses. Risk management is particularly important in cyclical industries that are heavily influenced by economic shifts.
For informational purposes only. Not an investment recommendation.
This material is provided for limited purposes. It is not intended as an offer or solicitation for the purchase or sale of any financial instrument, or any Putnam product or strategy. References to specific asset classes and financial markets are for illustrative purposes only and are not intended to be, and should not be interpreted as, recommendations or investment advice. The opinions expressed in this article represent the current, good-faith views of the author(s) at the time of publication. The views are provided for informational purposes only and are subject to change. This material does not take into account any investor’s particular investment objectives, strategies, tax status, or investment horizon. Investors should consult a financial advisor for advice suited to their individual financial needs. Putnam Investments cannot guarantee the accuracy or completeness of any statements or data contained in the article. Predictions, opinions, and other information contained in this article are subject to change. Any forward-looking statements speak only as of the date they are made, and Putnam assumes no duty to update them. Forward-looking statements are subject to numerous assumptions, risks, and uncertainties. Actual results could differ materially from those anticipated. Past performance is not a guarantee of future results. As with any investment, there is a potential for profit as well as the possibility of loss.
Diversification does not guarantee a profit or ensure against loss. It is possible to lose money in a diversified portfolio.
Consider these risks before investing: International investing involves certain risks, such as currency fluctuations, economic instability, and political developments. Investments in small and/or midsize companies increase the risk of greater price fluctuations. Bond investments are subject to interest-rate risk, which means the prices of the fund’s bond investments are likely to fall if interest rates rise. Bond investments also are subject to credit risk, which is the risk that the issuer of the bond may default on payment of interest or principal. Interest-rate risk is generally greater for longer-term bonds, and credit risk is generally greater for below-investment-grade bonds, which may be considered speculative. Unlike bonds, funds that invest in bonds have ongoing fees and expenses. Lower-rated bonds may offer higher yields in return for more risk. Funds that invest in government securities are not guaranteed. Mortgage-backed securities are subject to prepayment risk. Commodities involve the risks of changes in market, political, regulatory, and natural conditions. You can lose money by investing in a mutual fund.
Putnam Retail Management.